Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.
In prostate cancer, two different types of histone lysine demethylases (KDM), LSD1/KDM1 and JMJD2/KDM4, are coexpressed and colocalize with the androgen receptor. We designed and synthesized hybrid LSD1/JmjC or "pan-KDM" inhibitors 1-6 by coupling the skeleton of tranylcypromine 7, a known...
Hoofdauteurs: | Rotili, D, Tomassi, S, Conte, M, Benedetti, R, Tortorici, M, Ciossani, G, Valente, S, Marrocco, B, Labella, D, Novellino, E, Mattevi, A, Altucci, L, Tumber, A, Yapp, C, King, O, Hopkinson, R, Kawamura, A, Schofield, C, Mai, A |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2014
|
Gelijkaardige items
-
Crystal structure of the PHF8 Jumonji domain, an Nepsilon-methyl lysine demethylase
door: Yue, W, et al.
Gepubliceerd in: (2010) -
Crystal structure of the PHF8 Jumonji domain, an Nepsilon-methyl lysine demethylase.
door: Yue, W, et al.
Gepubliceerd in: (2010) -
Targeting histone lysine demethylases - Progress, challenges, and the future.
door: Thinnes, C, et al.
Gepubliceerd in: (2014) -
A miniaturized screen for inhibitors of Jumonji histone demethylases.
door: Sakurai, M, et al.
Gepubliceerd in: (2010) -
A miniaturized screen for inhibitors of Jumonji histone demethylases.
door: Sakurai, M, et al.
Gepubliceerd in: (2010)